Reference. Validation of a Diabetes Subtype Classification Model Using Data from U.S. Adults Before and After the COVID-19 Pandemic
Background: We (and others) have previously identified five clinically distinct diabetes subtypes. Currently, few models to identify diabetes subtypes are readily accessible. Further, while COVID-19 has been associated with increased risk of new-onset diabetes, it remains unknown whether the pandemic is also associated with changes in diabetes subtype distribution. Methods: We used the electronic health records of patients diagnosed with diabetes from 2010 to 2019 at the Kirklin Clinic of the University of Alabama at Birmingham (UAB) to train models to assign diabetes subtypes previously identified by hierarchical clustering. We then applied the trained model to conduct a retrospective cluster analysis of electronic health records of patients diagnosed with diabetes from 2020 to 2024 at UAB. We further validated our findings using data from the 2015–2023 National Health and Nutrition Examination Surveys (NHANES). Results: The trained classification model had an average specificity of 98% and an average sensitivity of 93%. Using the model, we identified a significant difference in the distribution of type 2 diabetes subtypes in patients at UAB and in participants in NHANES. In particular, the proportion of patients with severe insulin-dependent diabetes or severe insulin-resistant diabetes subtypes increased from 42% to 61% and 31% to 40% at the UAB and in NHANES, respectively. Conclusions: The model presented here can facilitate the identification of diabetes subtypes. The proportions of patients with severe subtypes of diabetes have seemed to increase in the more recent years following the pandemic. Further studies are required to determine the potential causes of this phenomenon.
Cite
Cites 40 works (0 here)
External (40)
- Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: A prospective cohort study in Sweden (2026)
- 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes—2026 (2026)
- 13. Older adults: standards of care in diabetes—2026 (2026)
- Data-driven Cluster Analysis Reveals Increased Risk for Severe Insulin-deficient Diabetes in Black/African Americans (2025)
- Prevalence and control of diabetes among US adults, 2013 to 2023 (2025)
- A web-based application for diabetes subtyping: The DDZ Diabetes-Cluster-Tool (2025)
- Development and Validation of DIANA (Diabetes Novel Subgroup Assessment tool): A web-based precision medicine tool to determine type 2 diabetes endotype membership and predict individuals at risk of microvascular disease (2025)
- nhanesA: Achieving transparency and reproducibility in NHANES research (2024)
- Human vascularized macrophage-islet organoids to model immune-mediated pancreatic beta cell pyroptosis upon viral infection (2024)
- Machine learning-based reproducible prediction of type 2 diabetes subtypes (2024)
- Identifying subtypes of type 2 diabetes mellitus with machine learning: Development, internal validation, prognostic validation and medication burden in linked electronic health records in 420,448 individuals (2024)
- Diabetes Management Based on the Phenotype and Stage of the Disease: An Expert Proposal from the AGORA Diabetes Collaborative Group (2024)
- Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes (2024)
- Prevalence of total, diagnosed, and undiagnosed diabetes in adults: United States, August 2021–August 2023 (NCHS Data Brief) (2024)
- Association of COVID-19 Vaccination with Risk for Incident Diabetes After COVID-19 Infection (2023)
- Precision subclassification of type 2 diabetes: A systematic review (2023)
- Machine learning based study for the classification of Type 2 diabetes mellitus subtypes (2023)
- Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis (2022)
- Association of COVID-19 with diabetes: A systematic review and meta-analysis (2022)
- The impact of the COVID-19 pandemic on diabetes services: Planning for a global recovery (2022)
- Correlation between insulin-based and C-peptide based homeostatic model assessment of insulin resistance in adults without diabetes in a sub-Saharan African setting: a cross-sectional study (2022)
- A novel diabetes typology: Towards precision diabetology from pathogenesis to treatment (2022)
- Clinical Characteristics and Risk of Diabetic Complications in Data-Driven Clusters Among Type 2 Diabetes (2021)
- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes (2021)
- SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment (2021)
- Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (2021)
- 100 YEARS OF INSULIN: Towards improved precision and a new classification of diabetes mellitus (2021)
- Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: An IMI-RHAPSODY study (2021)
- Not All Patients with Type 2 Diabetes Are Equal (2021)
- Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis (2020)
- Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach (2020)
- From Local Explanations to Global Understanding with Explainable AI for Trees (2020)
- Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel (2020)
- Novel subgroups of patients with adult-onset diabetes in Chinese and US populations (2019)
- Comparison of different models of insulin resistance in T2DM: A cross-sectional study (2019)
- Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables (2018)
- Hepatic but Not Extrahepatic Insulin Clearance Is Lower in African American Than in European American Women (2017)
- Insulin clearance is different in men and women (2012)
- Correlation between measures of insulin resistance in fasting and non-fasting blood (2011)
- Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man (1985)